suzuki kensuke 鈴木健介

… Alternative Names

鈴木健介スズキケンスケ

Less

Researcher Number	80533182
Other IDs
Affiliation (Current)	2025: 関西医科大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2025: 関西医科大学, 医学部, 准教授 2023: 関西医科大学, 医学部, 准教授 2022: 関西医科大学, 医学部, 講師 2018: 関西医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 56050:Otorhinolaryngology-related Except Principal Investigator Basic Section 56050:Otorhinolaryngology-related
Keywords	Principal Investigator 分子標的薬併用放射線療法 / I-131抵抗性 / I-131 / レンバチニブ / NIS / 甲状腺癌 Except Principal Investigator 健康寿命 / 老人性難聴 / 骨髄移植 / oxi-inflamm-aging … More / 慢性炎症 / 蝸牛 / 酸化ストレス / 免疫若返り / 老化促進モデルマウス / 加齢性難聴 / 造血幹細胞 Less

ナトリウムヨウ素共輸送体の機能亢進と腫瘍血管正常化によるI-131抵抗性の克服Principal Investigator
- Principal Investigator
  
  鈴木健介
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kansai Medical University
Prevention of age-related hearing loss using bone marrow transplantation
- Principal Investigator
  
  岩井大
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kansai Medical University
I-131抵抗性の克服による甲状腺癌に対する新規分子標的薬併用放射線療法の開発Principal Investigator
- Principal Investigator
  
  鈴木健介
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kansai Medical University
新規ヒト唾液腺培養細胞がん化モデルの開発とがん化制御の試みPrincipal Investigator
- Principal Investigator
  
  鈴木健介
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kansai Medical University

All 2024 2023 2022 Other

All Journal Article Presentation Other

[Journal Article] Mouse eosinophil‐associated ribonuclease‐2 exacerbates the allergic response2024
- Author(s)
  Nguyen Linh Manh、Kanda Akira、Kamioka Yuji、Tokuhiro Keizo、Kobayashi Yoshiki、Yun Yasutaka、Bui Dan Van、Chu Hanh Hong、Le Nhi Kieu Thi、Suzuki Kensuke、Mitani Akitoshi、Shimamura Akihiro、Fukui Kenta、Dombrowicz David、Iwai Hiroshi
- Journal Title
  
  Allergy
  
  Volume: - Issue: 8 Pages: 1-5
- DOI
  10.1111/all.16061
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K08999, KAKENHI-PROJECT-21K06181, KAKENHI-PROJECT-21K09593
[Journal Article] CD69 Signaling in Eosinophils Induces IL-10 Production and Apoptosis via the Erk1/2 and JNK Pathways, Respectively.2024
- Author(s)
  Bui DV, Nguyen LM, Kanda A, Chu HH, Thi Le NK, Yun Y, Kobayashi Y, Suzuki K, Mitani A, Shimamura A, Fukui K, Sawada S, Dombrowicz D, Iwai H.
- Journal Title
  
  Biomolecules.
  
  Volume: 14 Issue: 3 Pages: 360-360
- DOI
  10.3390/biom14030360
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K15876, KAKENHI-PROJECT-23K08999, KAKENHI-PROJECT-21K09593
[Journal Article] Potential of combination therapy with lenvatinib and radiation for thyroid cancer2022
- Author(s)
  鈴木健介，岩井大，宇都宮啓太，河野由美子，小林良樹，尹泰貴, 三谷彰俊，福井研太，酒井遥，谷川昇，神田晃
- Journal Title
  
  The Journal of Kansai Medical University
  
  Volume: 73 Issue: 0 Pages: 1-5
- DOI
  10.5361/jkmu.73.1
- ISSN
  0022-8400, 2185-3851
- Language
  Japanese
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K16921, KAKENHI-PROJECT-20K18269, KAKENHI-PROJECT-20K18297
[Journal Article] Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model2022
- Author(s)
  Kensuke Suzuki, Hiroshi Iwai, Keita Utsunomiya, Yumiko Kono, Tadashi Watabe, Yoshiki Kobayashi, Dan Van Bui, Shunsuke Sawada, Yasutaka Yun, Akitoshi Mitani, Kenta Fukui, Haruka Sakai, Hanh Hong Chu, Nguyen Manh Linh, Noboru Tanigawa and Akira Kanda
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 23(17) Issue: 17 Pages: 9872-9872
- DOI
  10.3390/ijms23179872
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K16921, KAKENHI-PROJECT-20K18269, KAKENHI-PROJECT-20K18297
[Presentation] naive T 細胞供給による加齢性難聴の予防と機序の解明2023
- Author(s)
  三谷　彰俊、岩井　大、Nguyen　Manh　Linh、Le　Thi　Kieu　Nhi、嶋村　晃宏、福井　研太、尹　泰貴、鈴木　健介、小林　良樹、神田　晃
- Organizer
  第40回ニューロサイエンス研究会
- Data Source
  KAKENHI-PROJECT-23K08999
[Presentation] 甲状腺癌に対するレンバチニブとRAIの併用療法2022
- Author(s)
  鈴木健介
- Organizer
  第34回　日本内分泌外科学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-22K16921
[]

1. 岩井大 (10232638)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
2. 小林良樹 (10375298)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
3. 稲葉宗夫 (70115947)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 神田晃 (70375244)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
5. 尹泰貴

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

suzuki kensuke 鈴木 健介

鈴木 健介 スズキ ケンスケ

Research Projects

Research Products

Co-Researchers

ナトリウムヨウ素共輸送体の機能亢進と腫瘍血管正常化によるI-131抵抗性の克服Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Prevention of age-related hearing loss using bone marrow transplantation

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

I-131抵抗性の克服による甲状腺癌に対する新規分子標的薬併用放射線療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

新規ヒト唾液腺培養細胞がん化モデルの開発とがん化制御の試みPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Mouse eosinophil‐associated ribonuclease‐2 exacerbates the allergic response2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] CD69 Signaling in Eosinophils Induces IL-10 Production and Apoptosis via the Erk1/2 and JNK Pathways, Respectively.2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Potential of combination therapy with lenvatinib and radiation for thyroid cancer2022

Author(s)

Journal Title

DOI

ISSN

Language

Data Source

[Journal Article] Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model2022

Author(s)

Journal Title

DOI

Data Source

[Presentation] naive T 細胞供給による加齢性難聴の予防と機序の解明2023

Author(s)

Organizer

Data Source

[Presentation] 甲状腺癌に対するレンバチニブとRAIの併用療法2022

Author(s)

Organizer

Data Source

[]

suzuki kensuke 鈴木健介

鈴木健介スズキケンスケ